HF
SOPH icon

HRT Financial’s SOPHiA GENETICS SOPH Stock Holding History

HRT Financial’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130K Buy
+22,532
New +$114K ﹤0.01% 3544

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

HRT Financial's SOPH Position: Q2 2026 in Review

HRT Financial opened a new position in SOPHiA GENETICS (SOPH) in Q2 2026: 22,532 shares worth $130K. The stake represents ﹤0.01% of the portfolio and ranks #3544 among its holdings.

72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • HRT Financial held 22,532 shares of SOPHiA GENETICS worth $130K as of Q2 2026.
  • SOPHiA GENETICS was a new HRT Financial position in Q2 2026.
  • SOPHiA GENETICS made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3544 holding.
  • 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.